New brain bleed treatment shows promise in major trial
NCT ID NCT07208097
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests a new way to treat a serious type of brain bleed (intracerebral hemorrhage). It compares standard medical care to a minimally invasive procedure that uses a small tube to drain the blood clot and deliver a clot-busting drug (tenecteplase). The goal is to see if this approach helps more people recover with less disability after 6 months. The trial plans to enroll 768 adults aged 18-80 with a specific size of brain bleed.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for INTRACEREBRAL HAEMORRHAGE are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Guizhou Medical University Affiliated Hospital
ACTIVE_NOT_RECRUITINGGuiyang, Guizhou, 550000, China
-
Suzhou First People's Hospital
RECRUITINGSuzhou, Anhui, 234000, China
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Ambulance vital signs may hold clues to brain bleeding outcomes
- New drug algorithm aims to quickly lower blood pressure in brain bleed patients
- Massive german study to map stroke care from ambulance to recovery
- Could video calls and apps replace some rehab visits? small swiss study tests blended care for brain recovery
- Can a pill box and text messages keep stroke patients healthy?
- New care bundle aims to save lives after brain hemorrhage